The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice
Open accessAbstract
BACKGROUND & AIMS Inflammation may contribute to formation, maintenance, and expansion of cancer stem cells (CSCs), which have the capacity for self-renewal, differentiation, and resistance to cytotoxic agents. We investigated the effects of the inflammatory mediator prostaglandin E2 (PGE2) on colorectal CSC development and metastasis in mice and the correlation between levels of PGE2 and CSC markers in human colorectal cancer (CRC) specimens. METHODS Colorectal carcinoma specimens and matched normal tissues were collected from patients at the Mayo Clinic (Scottsdale, AZ) and analyzed by mass spectrometry and quantitative PCR. Human primary CRC cells and mouse tumor cells were isolated using microbeads and flow cytometry and analyzed in sphere-formation and flow cytometry assays. LS-174T cells were sorted by flow cytometry (for CD133+CD44+ and CD133−CD44− cells) and also used in these assays. NSG mice were given cecal or subcutaneous injections of LS-174T or human primary CRC cells. ApcMin/+ mice and NSG mice with orthotopic cecal tumors were given vehicle (controls), PGE2, celecoxib, or/and Ono-AE3-208. PGE2 downstream signaling pathways were knocked down with small hairpin RNAs, expressed from lentiviral vectors in LS-174T cells, or blocked with inhibitors in human primary CRC cells. RESULTS Levels of PGE2 correlated with colonic CSC markers (CD133, CD44, LRG5, and SOX2 mRNAs) in human colorectal carcinoma samples. Administration of PGE2 to ApcMin/+ mice increased tumor stem cells and tumor burden, compared with controls. NSG mice given PGE2 had increased numbers of cecal CSCs and liver metastases, compared with controls, after intracecal injection of LS-174T or human primary CRC cells. Alternatively, celecoxib, an inhibitor of prostaglandin-endoperoxide synthase 2 (PTGS2 or COX2), reduced polyp numbers in Apc Min/+ mice, liver metastasis in NSG mice with orthotopic tumors, and numbers of CSCs in ApcMin/+ and NSG mice. Inhibitors or knockdown of PGE receptor 4 (PTGER4 or EP4), PI3K p85α, ERK1, or nuclear factor (NF)-κB reduced PGE2-induced sphere formation by and expansion of LS-174T and/or human primary CRC cells. Knockdown of ERK1 or PI3K p85α also attenuated PGE2-induced activation of NF-κB in LS-174T cells. An EP4 antagonist reduced the ability of PGE2 to induce CSC expansion in orthotopic tumors and to accelerate formation of liver metastases. Knockdown experiments showed that NF-κB was required for PGE2 induction of CSCs and metastasis in mice. CONCLUSIONS PGE2 induces CSC expansion by activating NF-κB, via EP4–PI3K and EP4–MAPK signaling, and promotes formation of liver metastases in mice. The PGE2 signaling pathway might therefore be targeted therapeutically to slow colorectal cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007) · Nature · doi:10.1038/nature05372 · Cited by 4,087
Identification and expansion of human colon-cancer-initiating cells
Ricci-Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & De Maria, R. (2007) · Nature · doi:10.1038/nature05384 · Cited by 3,998
Tumour stem cells and drug resistance
Dean, M., Fojo, T., & Bates, S. (2005) · Nature reviews. Cancer · doi:10.1038/nrc1590 · Cited by 3,668
Phenotypic characterization of human colorectal cancer stem cells
Dalerba, P., Dylla, S. J., Park, I.-K., Liu, R., Wang, X., Cho, R. W., Hoey, T., Gurney, A., Huang, E. H., Simeone, D. M., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703478104 · Cited by 2,184
Wang, D., & DuBois, R. N. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2809 · Cited by 1,793
Self-citationCharafe-Jauffret, E., Ginestier, C., Iovino, F., Wicinski, J., Cervera, N., Finetti, P., Hur, M.-H., Diebel, M. E., Monville, F., Dutcher, J., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2741 · Cited by 1,173
Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
Schwitalla, S., Fingerle, A. A., Cammareri, P., Nebelsiek, T., Göktuna, S. I., Ziegler, P. K., Canli, O., Heijmans, J., Huels, D. J., Moreaux, G., et al. (2013) · Cell · doi:10.1016/j.cell.2012.12.012 · Cited by 1,068
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
North, T. E., Goessling, W., Walkley, C. R., Lengerke, C., Kopani, K. R., Lord, A. M., Weber, G. J., Bowman, T. V., Jang, I.-H., Grosser, T., et al. (2007) · Nature · doi:10.1038/nature05883 · Cited by 1,029
Wang, D. (2006) · Gut · doi:10.1136/gut.2004.047100 · Cited by 899
Self-citationProstaglandin E 2 Promotes Colon Cancer Cell Growth Through a G s -Axin-ß-Catenin Signaling Axis
Castellone, M. D., Teramoto, H., Williams, B. O., Druey, K. M., & Gutkind, J. S. (2005) · Science · doi:10.1126/science.1116221 · Cited by 883
The role of COX‐2 in intestinal inflammation and colorectal cancer
Wang, D., & DuBois, R. N. (2010) · Oncogene · doi:10.1038/onc.2009.421 · Cited by 805
Self-citationTodaro, M., Gaggianesi, M., Catalano, V., Benfante, A., Iovino, F., Biffoni, M., Apuzzo, T., Sperduti, I., Volpe, S., Cocorullo, G., et al. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.01.009 · Cited by 717
Cuzick, J., Otto, F., Baron, J. A., Brown, P. H., Burn, J., Greenwald, P., Jankowski, J., La Vecchia, C., Meyskens, F., Senn, H. J., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70035-x · Cited by 714
Goessling, W., North, T. E., Loewer, S., Lord, A. M., Lee, S., Stoick-Cooper, C. L., Weidinger, G., Puder, M., Daley, G. Q., Moon, R. T., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.015 · Cited by 699
Altered eicosanoid levels in human colon cancer.
Rigas, B., Goldman, I. S., & Levine, L. (1993) · PubMed · Cited by 569
NF-κB addiction and its role in cancer: ‘one size does not fit all’
Chaturvedi, M. M., Sung, B., Yadav, V. R., Kannappan, R., & Aggarwal, B. B. (2011) · Oncogene · doi:10.1038/onc.2010.566 · Cited by 473
EGFR/Ras/MAPK Signaling Mediates Adult Midgut Epithelial Homeostasis and Regeneration in Drosophila
Jiang, H., Grenley, M. O., Bravo, M.-J., Blumhagen, R. Z., & Edgar, B. A. (2011) · Cell Stem Cell · doi:10.1016/j.stem.2010.11.026 · Cited by 467
PTEN-deficient intestinal stem cells initiate intestinal polyposis
He, X. C., Yin, T., Grindley, J. C., Tian, Q., Sato, T., Tao, W. A., Dirisina, R., Porter-Westpfahl, K. S., Hembree, M., Johnson, T., et al. (2007) · Nature Genetics · doi:10.1038/ng1928 · Cited by 417
Newcomb, P. A., Baron, J., Cotterchio, M., Gallinger, S., Grove, J., Haile, R., Hall, D., Hopper, J. L., Jass, J., Le Marchand, L., et al. (2007) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-0648 · Cited by 389
Wang, D., Wang, H., Shi, Q., Katkuri, S., Walhi, W., Desvergne, B., Das, S. K., Dey, S. K., & DuBois, R. N. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.08.011 · Cited by 340
Self-citationLi, H.-J., Reinhardt, F., Herschman, H. R., & Weinberg, R. A. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0101 · Cited by 340
IL-1β promotes stemness and invasiveness of colon cancer cells through Zeb1 activation
Li, Y., Wang, L., Pappan, L., Galliher-Beckley, A., & Shi, J. (2012) · Molecular Cancer · doi:10.1186/1476-4598-11-87 · Cited by 319
Cyclooxygenase-2 Expression Is an Independent Predictor of Poor Prognosis in Colon Cancer
Ogino, S., Kirkner, G. J., Nosho, K., Irahara, N., Kure, S., Shima, K., Hazra, A., Chan, A. T., Dehari, R., Giovannucci, E. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1841 · Cited by 209
Non-steroidal anti-inflammatory drugs to potentiate chemotherapy effects: From lab to clinic
de Groot, D. J. A., de Vries, E. G. E., Groen, H. J. M., & de Jong, S. (2007) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.07.001 · Cited by 175
Cyclooxygenase-2: a potential target in breast cancer
Wang, D., & DuBois, R. N. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.01.008 · Cited by 172
Self-citationDrosophila Ras/MAPK signalling regulates innate immune responses in immune and intestinal stem cells
Ragab, A., Buechling, T., Gesellchen, V., Spirohn, K., Boettcher, A.-L., & Boutros, M. (2011) · The EMBO Journal · doi:10.1038/emboj.2011.4 · Cited by 146
Downregulation of prostaglandin E receptor subtype EP 3 during colon cancer development
Shoji, Y., Takahashi, M., Kitamura, T., Watanabe, K., Kawamori, T., Maruyama, T., Sugimoto, Y., Negishi, M., Narumiya, S., Sugimura, T., et al. (2004) · Gut · doi:10.1136/gut.2003.028787 · Cited by 145
Qiu, W., Wang, X., Leibowitz, B. J., Liu, H., Barker, N., Okada, H., Oue, N., Yasui, W., Clevers, H. C., Schoen, R. E., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010430107 · Cited by 101
Moon, C. M., Kwon, J., Kim, J. S., Oh, S., Lee, K. J., Park, J. J., Hong, S. P., Cheon, J. H., Kim, T. I., & Kim, W. H. (2013) · International Journal of Cancer · doi:10.1002/ijc.28381 · Cited by 96
Prospective Study of Urinary Prostaglandin E2 Metabolite and Colorectal Cancer Risk
Cai, Q., Gao, Y.-T., Chow, W., Shu, X., Yang, G., Ji, B., Wen, W., Rothman, N., Li, H. L., Morrow, J. D., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4931 · Cited by 93
Johnson, J. C., Schmidt, C. R., Shrubsole, M. J., Billheimer, D. D., Joshi, P., Morrow, J. D., Heslin, M. J., Washington, M. K., Ness, R. M., Zheng, W., et al. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.07.015 · Cited by 87
Majumder, M., Xin, X., Liu, L., Girish, G. V., & Lala, P. K. (2014) · Cancer Science · doi:10.1111/cas.12475 · Cited by 86
Cyclooxygenase-2-Derived Prostaglandin E2 Protects Mouse Embryonic Stem Cells from Apoptosis
Liou, J., Ellent, D. P., Lee, S. H., Goldsby, J. S., Ko, B., Matijevic, N., Huang, J.-C., & Wu, K. K. (2007) · Stem Cells · doi:10.1634/stemcells.2006-0505 · Cited by 78
Morris, P. G., Zhou, X. K., Milne, G. L., Goldstein, D. A., Hawks, L. C., Dang, C. T., Modi, S., Fornier, M. N., Hudis, C. A., & Dannenberg, A. J. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0431 · Cited by 73
Inflammation linking EMT and cancer stem cells
Zhou, C., Liu, J., Tang, Y., & Liang, X. (2012) · Oral Oncology · doi:10.1016/j.oraloncology.2012.06.005 · Cited by 70
Kim, S., Taylor, J. A., Milne, G. L., & Sandler, D. P. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0040 · Cited by 56
Fan, Y.-Y., Davidson, L. A., Callaway, E. S., Goldsby, J. S., & Chapkin, R. S. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt412 · Cited by 55
Urinary Prostaglandin E2 Metabolite and Risk for Colorectal Adenoma
Shrubsole, M. J., Cai, Q., Wen, W., Milne, G. L., Smalley, W. E., Chen, Z., Ness, R. M., & Zheng, W. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0426 · Cited by 53
Development and Maintenance of Cancer Stem Cells under Chronic Inflammation
Tanno, T., & Matsui, W. H. (2011) · Journal of Nippon Medical School · doi:10.1272/jnms.78.138 · Cited by 40
Prostaglandins and activation of AC/cAMP prevents anoikis in IEC-18
Joseph, R. R., Yazer, E., Hanakawa, Y., & Stadnyk, A. W. (2005) · APOPTOSIS · doi:10.1007/s10495-005-2049-y · Cited by 33
Kekatpure, V. D., Boyle, J. O., Zhou, X. K., Duffield‐Lillico, A. J., Gross, N. D., Lee, N. Y., Subbaramaiah, K., Morrow, J. D., Milne, G. L., Lippman, S. M., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0093 · Cited by 24
(2003) · PubMed
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Pathways of Colorectal Carcinogenesis
Nguyen, L. H., Goel, A., & Chung, D. C. (2020) · Gastroenterology · doi:10.1053/j.gastro.2019.08.059 · Cited by 606
NF‐κB signaling in inflammation and cancer
Zhang, T., Ma, C., Zhang, Z., Zhang, H., & Hu, H. (2021) · MedComm · doi:10.1002/mco2.104 · Cited by 574
Cancer stem cells (CSCs) in cancer progression and therapy
Najafi, M., Farhood, B., & Mortezaee, K. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.27740 · Cited by 573
Cancer stem cells: advances in knowledge and implications for cancer therapy
Chu, X., Tian, W., Ning, J., Xiao, G., Zhou, Y., Wang, Z., Zhai, Z., Tanzhu, G., Yang, J., & Zhou, R. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01851-y · Cited by 553
Metadata
- Authors
- Wang, D., Fu, L., Sun, H., Guo, L., & DuBois, R. N.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 149
- Issue
- 7
- Pages
- 1884-1895.e4
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1092939784
- Cited by
- 292
- References
- 42
- FWCI
- 8.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.